Halios, Baby Girl P.

HRN: 22-99-47  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/02/2023
CEFTAZIDIME 1GM (VIAL)
05/02/2023
05/09/2023
IV
95mg
Q12hours
Neonatal Pneumonia
Waiting Final Action 
05/02/2023
GENTAMICIN 40MG/ML, 2ML (AMP)
05/02/2023
05/09/2023
IV
9.5mg
Q24hours
Neonatal Pneumonia
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: